Renal disease News and Research

RSS

Myogen's Ambrisentan granted orphan drug designation by Europeans

Myogen today announced that the Commission of the European Communities, with a favorable opinion of the Committee for Orphan Medicinal Products of the European Medicines Agency (EMEA), has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension.

2 May 2005

New guidelines for managing chronic kidney disease in patients living with HIV infection

The HIV Medicine Association has released guidelines for managing chronic kidney disease in patients living with HIV infection. They are published in the June 1 issue of Clinical Infectious Diseases.

27 Apr 2005

Hemodialysis causes antioxidant loss leading to long-term complications

An article published in Hemodialysis International discusses the role of oxidative stress (OS) in dialysis patients, an imbalance which can result in long-term health problems. Potential therapeutic options to restore balance in patients are also reviewed.

10 Apr 2005

Role of oxidative stress (OS) in dialysis patients

7 Apr 2005

Kidney transplant can reverse systolic heart failure

Doctors at the University of Maryland Medical Center say that contrary to conventional thinking, a kidney transplant can significantly improve the heart function of people on dialysis with a serious form of heart failure.

6 Apr 2005

Stent graft outperforms balloon angioplasty

A large, multi-center trial of 190 patients shows a new nonsurgical interventional radiology technique can benefit the more than 287,000 kidney failure patients undergoing dialysis in the United States each year.

4 Apr 2005

Hemodialysis causes antioxidant loss leading to long-term complications

30 Mar 2005

KCP protein protects kidneys from damage caused by chronic renal disease and injury

University of Michigan scientists have identified a new and unusual protein that reduces, in laboratory mice, kidney damage caused by chronic renal disease and acute toxic injuries.

28 Mar 2005

New study to evaluate Pegasys and Copegus to treat hepatitis C in liver transplant patients

Roche has initiated a new study to evaluate treatment strategies to reduce post-transplant recurrence of hepatitis C infection with the most prescribed hepatitis C treatment combination in the U.S., Pegasys (peginterferon alfa-2a) and Copegus (ribavirin, USP).

21 Mar 2005

Suitcase-sized machine helps patients undergoing rigorous dialysis for kidney failure

A suitcase-sized machine tested at the Indiana University School of Medicine is making life easier for some patients undergoing rigorous dialysis for kidney failure.

7 Mar 2005

NIH awards grant to explore causal relationship between epoetin dose and survival of hemodialysis patients

The National Institutes of Health, National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) has awarded a two-year grant to the Medical Technology and Practice Patterns Institute (MTPPI) in collaboration with Harvard School of Public Health (HSPH) to explore the causal relationship between epoetin dose and survival of hemodialysis patients receiving this therapy.

27 Feb 2005

Government grant pumps Vascam`s commercialisation

VasCam Pty Ltd has been awarded a Queensland Government Innovation Start-up Scheme (ISUS) grant which will help progress its technology to the clinical trial stage.

23 Feb 2005

Achieva 3T MR Scanner launched officially launched

The first 'next generation' MRI (magnetic resonance imaging) body scanner in the world will be officially launched at Hope Hospital later this week (Friday 18th February).

15 Feb 2005

Risks of obesity in children with kidney transplants

Obese children who get kidney transplants tend to be younger, shorter and on dialysis longer than their leaner peers, according to a study in the February issue of the journal Pediatrics.

7 Feb 2005

Sit down rounds improve outcomes for kidney dialysis patients

"Sit-down" medical rounds, during which a health care team meets to review a patient's medical record and discuss short- and long-term needs, are associated with better outcomes for kidney dialysis patients, a Johns Hopkins-directed study has found.

17 Nov 2004

Hospital admissions for diabetes on the rise

The number of hospital admissions for diabetes increased by almost 12 percent between 1999 and 2003, according to a new report released by the Pennsylvania Health Care Cost Containment Council (PHC4) in conjunction with American Diabetes Month.

11 Nov 2004

Canada puts in place a national plan to ensure an adequate flu vaccine supply

Per capita, more Canadians receive the flu shot than residents of any other country. The flu vaccine is the best protection against the flu virus, so it is encouraging to see that even more Canadians are getting the flu shot this season than ever before.

11 Nov 2004

The first test in humans of a bioartificial kidney

The first test in humans of a bioartificial kidney offers hope of the device's potential to save the lives of people with acute renal failure, researchers at the University of Michigan Health System report.

4 Nov 2004

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology’s 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.

1 Nov 2004

Controversial theory about how diabetes causes extensive tissue damage

A controversial theory about how diabetes causes extensive tissue damage will appear in the November issue of Diabetes. At stake in the heated debate over the theory are researchers' efforts to find new ways to reduce loss of vision, kidney failure, heart damage and other side effects of diabetes.

29 Oct 2004